Lifestyle induced weight loss and Liraglutide in the treatment of NASH
- Registry ID
- EUCTR2016-002045-36
- Source registry
- EUCTR
- Status
- Prematurely Ended
- Phase
- PHASE2
- Sponsor
- University of Oxford, Clinical Trials and Research Governance
- Start date
- 2016-11-17
- Completion date
- 2019-04-20
- Last update
- 2026-08-16
Conditions
- Non-alcoholic steatohepatitis (NASH)
Summary
To determine if treatment with Liraglutide improves liver fat and inflammation (non-alcoholic steatohepatitis, NASH), more than matched weight loss alone
Locations
View on source registry